Michael D. McNeil - 19 Aug 2025 Form 4 Insider Report for Sanara MedTech Inc. (SMTI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Aug 2025, 17:17:20 UTC
Prior SEC filing
11 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael D. McNeil

Key filing fact

Michael D. McNeil filed Form 4 for Sanara MedTech Inc. (SMTI) on 19 Aug 2025.

Key facts

  • This page summarizes Michael D. McNeil's Form 4 filing for Sanara MedTech Inc. (SMTI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Aug 2025, 17:17.

Change

  • Previous filing in this sequence was filed on 11 Apr 2025.
  • Current net transaction value: -$71,719.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001737969 Primary reporting owner

McNeil Michael D.

Relationship
Ch. Acct. & Ch. Admin. Officer
Address
1200 SUMMIT AVE, SUITE 414, FORT WORTH
Signature
/s/ Michael D. McNeil
Signature date
19 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SMTI transaction

Common Stock

Tax liability

Transaction value
$71,719
Shares
-2,324
Change %
-7.5%
Price
$30.86
Shares after
28,587
Date
19 Aug 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Michael D. McNeil is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the accelerated vesting of 9,543 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .